[99MTechnetium-fibrinogen labeling using electrolytic zircuronium release]
[Article in
German]
- PMID: 1178516
Item in Clipboard
[99MTechnetium-fibrinogen labeling using electrolytic zircuronium release]
[Article in
German]
Nucl Med (Stuttg).
.
Abstract
An electrolytic method for labelling fibrinogen with zirconium as a reductant for 99mTc is presented. The optimal labelling conditions and the in-vitro screening are subject of the study. First clinical experience indicates that the substance is clottable in vivo and applicable for localization.
Similar articles
-
Technetium-99m-human fibrinogen.J Nucl Med. 1975 May;16(5):343-7. J Nucl Med. 1975. PMID: 1194984
-
[Use of redox polymers for insulin labeling with technetium (99mTc)].Ceska Slov Farm. 1999 Sep;48(5):218-20. Ceska Slov Farm. 1999. PMID: 10566241 Czech.
-
Electrolytic complexation of 99mTc at constant current: its applications in nuclear medicine.J Nucl Med. 1970 Apr;11(4):147-54. J Nucl Med. 1970. PMID: 5434843 No abstract available.
-
In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent.J Nucl Med. 1976 Jan;17(1):40-6. J Nucl Med. 1976. PMID: 1244446
-
Recent developments in blood cell labeling research.Acta Radiol Suppl. 1990;374:103-8. Acta Radiol Suppl. 1990. PMID: 1966954 Review.
Cited by
-
A chemical method for the labeling of fibrinogen with 99mTc.Eur J Nucl Med. 1978 Apr 1;3(2):95-100. doi: 10.1007/BF00251631. Eur J Nucl Med. 1978. PMID: 750207
-
67 Ga-labeled human fibrinogen: a new promising thrombus imaging agent.Eur J Nucl Med. 1982;7(10):458-61. doi: 10.1007/BF00253082. Eur J Nucl Med. 1982. PMID: 7140780